Xenon Pharmaceuticals Inc. (XENE)

Latest Insider Confidence Score

2026Q1

47.7
Bearish

Company insider confidence (by quarter)

2014Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Evans Johnston L — 444,655 Nov 12, 2014
Bvf Partners L P/Il 10% Owner 238,000 Mar 29, 2018
Biotechnology Value Fund L P Other 238,000 Mar 29, 2018
Biotechnology Value Fund II Lp Other 238,000 Mar 29, 2018
Biotechnology Value Trading Fund OS LP Other 238,000 Mar 29, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 9, 2026 Jan 9, 2026 KENNEY CHRISTOPHER JOHN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2026 Jan 9, 2026 Cline Darren S Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2026 Jan 9, 2026 DiFabio Andrea Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2026 Jan 9, 2026 MORTIMER IAN CEO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 2, 2026 MORTIMER IAN CEO Sell 8.8 -40,000 -66.33% ✓ $1.8M
Dec 5, 2025 Dec 9, 2025 MORTIMER IAN CEO Sell 5.0 -25,205 -55.39% ✓ $1.1M
Nov 28, 2025 Dec 3, 2025 MORTIMER IAN CEO Sell 55.0 -97 -0.21% ✓ $4.4K
Oct 15, 2025 Oct 17, 2025 Kelly Thomas Patrick CFO Neutral 52.5 - 0.00% ✗ -
Oct 17, 2025 Kelly Thomas Patrick CFO Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 1, 2025 MORTIMER IAN CEO Sell 5.0 -25,000 -35.41% ✓ $1M
Jun 23, 2025 Jun 24, 2025 Cline Darren S Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jun 24, 2025 Cline Darren S Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 PATOU GARY Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Gover Justin D. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 GAROFALO ELIZABETH A. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 GANNON STEVEN Director Sell 52.5 -3 -0.04% ✗ $91.4
Jun 5, 2025 Jun 6, 2025 Cannon Gillian Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Svoronos Dawn Director Neutral 52.5 - 0.00% ✗ -
May 14, 2025 May 16, 2025 GANNON STEVEN Director Neutral 52.5 - 0.00% ✗ -
Mar 12, 2025 Mar 13, 2025 MORTIMER IAN CEO Neutral 52.5 - 0.00% ✗ -
Mar 12, 2025 Mar 13, 2025 KENNEY CHRISTOPHER JOHN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 12, 2025 Mar 13, 2025 DiFabio Andrea Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Jan 23, 2025 Jan 27, 2025 MORTIMER IAN CEO Sell 5.0 -55,000 -28.28% ✓ $2.2M
Dec 18, 2024 Dec 19, 2024 AULIN SHERRY CFO Sell 17.5 -25,334 -57.52% ✗ $1M
Nov 22, 2024 Nov 22, 2024 PATOU GARY Director Sell 20.0 -6,586 -5.95% ✗ $268.4K
Jun 5, 2024 Jun 5, 2024 PATOU GARY Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 5, 2024 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 5, 2024 Gover Justin D. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 5, 2024 GAROFALO ELIZABETH A. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 5, 2024 GANNON STEVEN Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 5, 2024 Cannon Gillian Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 5, 2024 Svoronos Dawn Director Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 Von Seggern Christopher Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 AULIN SHERRY CFO Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 KENNEY CHRISTOPHER JOHN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 EMPFIELD JAMES R. EVP, Drug Discovery Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 ROBIN SHERRINGTON EVP, Strategy & Innovation Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 DiFabio Andrea Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Mar 11, 2024 Mar 12, 2024 MORTIMER IAN CEO Neutral 52.5 - 0.00% ✗ -
Mar 8, 2024 Mar 11, 2024 GAROFALO ELIZABETH A. Director Sell 22.5 -3,500 -100.00% ✗ $160.6K
Mar 7, 2024 Mar 8, 2024 ROBIN SHERRINGTON EVP, Strategy & Innovation Sell 20.0 -8,641 -15.29% ✗ $399.4K
Mar 7, 2024 Mar 8, 2024 GANNON STEVEN Director Sell 20.0 -13,000 -86.67% ✗ $601.6K
Dec 29, 2023 Jan 2, 2024 ROBIN SHERRINGTON EVP, Strategy & Innovation Neutral 27.5 -8,398 -50.00% ✗ -
Dec 19, 2023 Dec 20, 2023 AZAB MOHAMMAD Director Neutral 52.5 - 0.00% ✗ -
Dec 14, 2023 Dec 15, 2023 PATOU GARY Director Sell 20.0 -7,598 -60.78% ✗ $311.9K
Dec 13, 2023 Dec 15, 2023 PATOU GARY Director Sell 20.0 -22,000 -12.24% ✗ $878.9K
Aug 24, 2023 Aug 24, 2023 Svoronos Dawn Director Sell 20.0 -25,000 -50.00% ✗ $967.5K
Aug 10, 2023 Aug 10, 2023 Gover Justin D. Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Gover Justin D. Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 10, 2023 Cannon Gillian Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Cannon Gillian Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 AZAB MOHAMMAD Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 PATOU GARY Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 GANNON STEVEN Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 Svoronos Dawn Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 GAROFALO ELIZABETH A. Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 PIMSTONE SIMON N. Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 2, 2023 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
May 30, 2023 Jun 1, 2023 PIMSTONE SIMON N. Director Sell 16.3 -183,159 -48.92% ✗ $7.1M
May 24, 2023 May 26, 2023 MORTIMER IAN CEO Sell 17.5 -44,038 -17.17% ✗ $1.8M
Mar 24, 2023 Mar 24, 2023 KENNEY CHRISTOPHER JOHN Chief Medical Officer Sell 26.3 -700 -100.00% ✗ $24.5K
Mar 10, 2023 Mar 14, 2023 Von Seggern Christopher Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 ROBIN SHERRINGTON EVP, Strategy & Innovation Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 DiFabio Andrea Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 MORTIMER IAN CEO Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 KENNEY CHRISTOPHER JOHN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 EMPFIELD JAMES R. EVP, Drug Discovery Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 AULIN SHERRY CFO Neutral 52.5 - 0.00% ✗ -
Mar 7, 2023 Mar 9, 2023 PIMSTONE SIMON N. Director Sell 20.0 -23,010 -10.45% ✗ $851.5K
Dec 12, 2022 Dec 13, 2022 AZAB MOHAMMAD Director Neutral 52.5 - 0.00% ✗ -
Nov 23, 2022 Nov 28, 2022 PATOU GARY Director Sell 22.5 -4,114 -4.61% ✗ $142.1K
Nov 7, 2022 Nov 9, 2022 DiFabio Andrea Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Nov 9, 2022 DiFabio Andrea Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Sep 2, 2022 Sep 7, 2022 AULIN SHERRY CFO Sell 20.0 -18,648 -100.00% ✗ $737.8K
Aug 31, 2022 Sep 2, 2022 ROBIN SHERRINGTON EVP, Strategy & Innovation Sell 17.5 -72,924 -31.58% ✗ $2.8M
Aug 12, 2022 Aug 16, 2022 EMPFIELD JAMES R. EVP, Drug Discovery Sell 17.5 -65,000 -86.67% ✗ $2.5M
Aug 12, 2022 Aug 16, 2022 PIMSTONE SIMON N. Director Sell 16.3 -177,135 -96.72% ✗ $6.8M
Jun 28, 2022 Jun 29, 2022 PIMSTONE SIMON N. Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 Svoronos Dawn Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 PATOU GARY Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 GAROFALO ELIZABETH A. Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 GANNON STEVEN Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 AZAB MOHAMMAD Director Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 Von Seggern Christopher Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 ROBIN SHERRINGTON EVP, Strategy & Innovation Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 PIMSTONE SIMON N. Chair Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 MORTIMER IAN CEO Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 KENNEY CHRISTOPHER JOHN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 AULIN SHERRY CFO Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Mar 14, 2022 EMPFIELD JAMES R. EVP, Drug Discovery Neutral 52.5 - 0.00% ✗ -
Mar 8, 2022 Mar 8, 2022 PIMSTONE SIMON N. Director Sell 22.5 -2,500 -1.28% ✗ $77K
Mar 4, 2022 Mar 8, 2022 PIMSTONE SIMON N. Director Sell 17.5 -57,915 -1.64% ✗ $1.7M
Mar 4, 2022 Mar 8, 2022 ROBIN SHERRINGTON EVP, Strategy & Innovation Sell 20.0 -22,406 -14.54% ✗ $684.1K
Mar 4, 2022 Mar 8, 2022 EMPFIELD JAMES R. EVP, Drug Discovery Sell 17.5 -67,500 -31.91% ✗ $2.1M
Jan 21, 2022 Jan 21, 2022 KENNEY CHRISTOPHER JOHN Chief Medical Officer Buy 91.3 +700 100.00% ✗ $20.2K
Dec 15, 2021 Dec 17, 2021 AZAB MOHAMMAD Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2021 Dec 10, 2021 PATOU GARY Director Neutral 52.5 - 0.00% ✗ -
Dec 6, 2021 Dec 7, 2021 Von Seggern Christopher Chief Commercial Officer Buy 95.0 +4,000 100.00% ✗ $97.6K